MENU
+Compare
PSTV
Stock ticker: NASDAQ
AS OF
Jul 3 closing price
Price
$0.30
Change
-$0.01 (-3.23%)
Capitalization
15.12M

PSTV Plus Therapeutics Forecast, Technical & Fundamental Analysis

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases... Show more

PSTV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for PSTV with price predictions
Jul 03, 2025

PSTV in -4.42% downward trend, declining for three consecutive days on July 03, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where PSTV declined for three days, in of 305 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Aroon Indicator for PSTV entered a downward trend on May 30, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where PSTV's RSI Oscillator exited the oversold zone, of 39 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 65 cases where PSTV's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on July 03, 2025. You may want to consider a long position or call options on PSTV as a result. In of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PSTV just turned positive on June 25, 2025. Looking at past instances where PSTV's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Following a +9 3-day Advance, the price is estimated to grow further. Considering data from situations where PSTV advanced for three days, in of 244 cases, the price rose further within the following month. The odds of a continued upward trend are .

PSTV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (16.678). P/E Ratio (0.000) is within average values for comparable stocks, (58.763). PSTV's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.315). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (269.614).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. PSTV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PSTV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
PSTV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

PSTV is expected to report earnings to fall 89.71% to -12 cents per share on August 16

Plus Therapeutics PSTV Stock Earnings Reports
Q2'23
Est.
$-0.12
Q1'25
Missed
by $0.46
Q4'24
Missed
by $0.01
Q1'23
Est.
$-0.14
Q4'22
Missed
by $0.62
The last earnings report on May 30 showed earnings per share of -119 cents, missing the estimate of -73 cents. With 4.14M shares outstanding, the current market capitalization sits at 15.12M.
A.I. Advisor
published General Information

General Information

a late stage cell therapy company, which engages in the development of autologous cell therapies from adipose tissue, using its proprietary technology, to treat a variety of medical conditions.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
4200 Marathon Boulevard
Phone
+1 737 255-7194
Employees
20
Web
https://www.plustherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FUNC33.810.57
+1.71%
First United Corp
DNA12.720.06
+0.47%
Ginkgo Bioworks Holdings
PSMT106.610.06
+0.06%
PriceSmart
ALGN196.82-0.16
-0.08%
Align Technology
KRKR5.31-0.19
-3.47%
36KR Holdings Inc

PSTV and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PSTV has been loosely correlated with OPT. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if PSTV jumps, then OPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PSTV
1D Price
Change %
PSTV100%
-3.52%
OPT - PSTV
35%
Loosely correlated
N/A
DRUG - PSTV
33%
Poorly correlated
+1.29%
PBIGF - PSTV
29%
Poorly correlated
N/A
ZYME - PSTV
28%
Poorly correlated
+1.16%
ARRY - PSTV
27%
Poorly correlated
+11.93%
More